Cargando…

Real-World Outcomes of Glucose Sensor Use in Type 1 Diabetes—Findings from a Large UK Centre

Flash glucose monitoring (FGM) and real-time continuous glucose monitoring (RT-CGM) are increasingly used in clinical practice, with improvements in HbA1c and time in range (TIR) reported in clinical studies. We aimed to evaluate the impact of FGM and RT-CGM use on glycaemic outcomes in adults with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kyuhan, Gunasinghe, Shakthi, Chapman, Alyson, Findlow, Lynne A., Hyland, Jody, Ohol, Sheetal, Urwin, Andrea, Rutter, Martin K., Schofield, Jonathan, Thabit, Hood, Leelarathna, Lalantha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615559/ https://www.ncbi.nlm.nih.gov/pubmed/34821673 http://dx.doi.org/10.3390/bios11110457

Ejemplares similares

Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England
por: Prabhu Navis, Joshi, et al.
Publicado: (2020)

COVID-19: Impact of and on Diabetes
por: Schofield, Jonathan, et al.
Publicado: (2020)

Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot
por: Thabit, Hood, et al.
Publicado: (2016)

Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK
por: Carr, Matthew J, et al.
Publicado: (2021)

Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care
por: Carr, Matthew J, et al.
Publicado: (2022)

Trends in HbA1c and other biochemical outcomes of individuals with newly diagnosed type 1 diabetes
por: O’Carroll-Lolait, A., et al.
Publicado: (2020)

Risk factor control and outpatient attendance in young adults with diabetes
por: Nadeem, F., et al.
Publicado: (2018)

Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial
por: Leelarathna, Lalantha, et al.
Publicado: (2013)

The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective
por: Leelarathna, Lalantha, et al.
Publicado: (2018)

Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study
por: Boughton, Charlotte K, et al.
Publicado: (2022)

Impact of the CamAPS FX hybrid closed‐loop insulin delivery system on sleep traits in older adults with type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2022)

Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes
por: Emami, Ali, et al.
Publicado: (2017)

Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents
por: Barnard, Katharine D, et al.
Publicado: (2014)

Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study
por: Lawton, Julia, et al.
Publicado: (2019)

Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions
por: Thabit, Hood, et al.
Publicado: (2015)

Glycaemic variability: The under‐recognized therapeutic target in type 1 diabetes care
por: Wilmot, Emma G., et al.
Publicado: (2019)

Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol
por: Leelarathna, Lalantha, et al.
Publicado: (2014)

Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2017)

Hypoglycaemia incidence and recovery during home use of hybrid closed‐loop insulin delivery in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2018)

Hyperglycemia and Death in Cystic Fibrosis–Related Diabetes
por: Adler, Amanda I., et al.
Publicado: (2011)

Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial
por: Hovorka, Roman, et al.
Publicado: (2014)

Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol
por: Wilmot, Emma G, et al.
Publicado: (2021)

Prevalence, associated factors and medication for symptoms related to gastroesophageal reflux disease among 1114 private-tuition students of Anuradhapura, Sri Lanka
por: Gunasinghe, Darsha, et al.
Publicado: (2020)

Patients’ and caregivers’ experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study
por: Lawton, J., et al.
Publicado: (2018)

Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes
por: Tauschmann, Martin, et al.
Publicado: (2015)

Continuous glucose monitoring in critically ill adults: comparison of two different calibration protocols
por: Leelarathna, L, et al.
Publicado: (2013)

Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter]
por: Moser, Othmar, et al.
Publicado: (2021)

Bolusing frequency and amount impacts glucose control during hybrid closed‐loop
por: Bally, L., et al.
Publicado: (2017)

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)
por: Moser, Othmar, et al.
Publicado: (2020)

Macroscopic mixer for disparate property liquid–liquid mixing in aqueous sanitizer preparation
por: Ohol, R. M., et al.
Publicado: (2021)

Coming of age: the artificial pancreas for type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2016)

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
por: Tauschmann, Martin, et al.
Publicado: (2018)

Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA(1c): A Real-world Observational Study
por: Crabtree, Thomas S.J., et al.
Publicado: (2023)

Comprehensive cardiovascular MRI in hypertension: a UK single centre experience
por: Pabari, Punam, et al.
Publicado: (2014)

Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist
por: Bally, Lia, et al.
Publicado: (2017)

Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol
por: Bally, Lia, et al.
Publicado: (2017)

Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses
por: Ohol, Yamini M., et al.
Publicado: (2015)

UK Centre for Bioscience, Higher Education Academy
por: Adams, David J.
Publicado: (2010)

Proximal myopathy in lacto-vegetarian Asian patients responding to Vitamin D and calcium supplement therapy - two case reports and review of the literature
por: Thabit, Hood, et al.
Publicado: (2011)

Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
por: Wing, James B., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_383md9tv0l40149jofv738lt3m